Tabic MB, šnypščiosios tabletės
Tabic MB, šnypščiosios tabletės
Authorised
- Infectious bursal disease virus, strain M.B., Live
Product identification
Medicine name:
Tabic MB, šnypščiosios tabletės
Active substance:
- Infectious bursal disease virus, strain M.B., Live
Target species:
-
Chicken
Route of administration:
-
Intraocular use
-
In drinking water use
Product details
Active substance and strength:
-
Infectious bursal disease virus, strain M.B., Live316.23/50% Embryo Infective Dose1.00Dose
Pharmaceutical form:
-
Effervescent tablet
Withdrawal period by route of administration:
-
In drinking water use
-
Chicken
-
Meat and offal0day
-
-
-
Ocular use
-
Chicken
-
Meat and offal0day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI01AD09
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Lithuania
Additional information
Entitlement type:
-
Parallel Trade Approval
Marketing authorisation date:
Responsible authority:
- State Food And Veterinary Service
Authorisation number:
- B1-859
Parallel trade in reference of:
Parallel trade of:
Source wholesaler:
- Vetmarket SIA
Destination wholesaler:
- Vetmarket UAB
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
